Hdl cholesterol and non-cardiovascular disease: A narrative review

Research output: Contribution to journalReviewResearchpeer-review

Standard

Hdl cholesterol and non-cardiovascular disease : A narrative review. / Kjeldsen, Emilie W.; Nordestgaard, Liv T.; Frikke-Schmidt, Ruth.

In: International Journal of Molecular Sciences, Vol. 22, No. 9, 4547, 2021.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Kjeldsen, EW, Nordestgaard, LT & Frikke-Schmidt, R 2021, 'Hdl cholesterol and non-cardiovascular disease: A narrative review', International Journal of Molecular Sciences, vol. 22, no. 9, 4547. https://doi.org/10.3390/ijms22094547

APA

Kjeldsen, E. W., Nordestgaard, L. T., & Frikke-Schmidt, R. (2021). Hdl cholesterol and non-cardiovascular disease: A narrative review. International Journal of Molecular Sciences, 22(9), [4547]. https://doi.org/10.3390/ijms22094547

Vancouver

Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. Hdl cholesterol and non-cardiovascular disease: A narrative review. International Journal of Molecular Sciences. 2021;22(9). 4547. https://doi.org/10.3390/ijms22094547

Author

Kjeldsen, Emilie W. ; Nordestgaard, Liv T. ; Frikke-Schmidt, Ruth. / Hdl cholesterol and non-cardiovascular disease : A narrative review. In: International Journal of Molecular Sciences. 2021 ; Vol. 22, No. 9.

Bibtex

@article{77ed91d3b96d44979edfcfd25949b7a9,
title = "Hdl cholesterol and non-cardiovascular disease: A narrative review",
abstract = "High density lipoprotein (HDL) cholesterol has traditionally been considered the “good cholesterol”, and most of the research regarding HDL cholesterol has for decades revolved around the possible role of HDL in atherosclerosis and its therapeutic potential within atherosclerotic cardiovascular disease. Randomized trials aiming at increasing HDL cholesterol have, however, failed and left questions to what role HDL cholesterol plays in human health and disease. Recent observational studies involving non-cardiovascular diseases have shown that high levels of HDL cholesterol are not necessarily associated with beneficial outcomes as observed for age-related macular degeneration, type II diabetes, dementia, infection, and mortality. In this narrative review, we discuss these interesting associations between HDL cholesterol and non-cardiovascular diseases, covering observational studies, human genetics, and plausible mechanisms.",
keywords = "Alzheimer{\textquoteright}s disease, Blindness, Diabetes, Drusen, Epidemiology, Genetics, High-density lipoprotein, Infection, Mortality",
author = "Kjeldsen, {Emilie W.} and Nordestgaard, {Liv T.} and Ruth Frikke-Schmidt",
year = "2021",
doi = "10.3390/ijms22094547",
language = "English",
volume = "22",
journal = "International Journal of Molecular Sciences (CD-ROM)",
issn = "1424-6783",
publisher = "M D P I AG",
number = "9",

}

RIS

TY - JOUR

T1 - Hdl cholesterol and non-cardiovascular disease

T2 - A narrative review

AU - Kjeldsen, Emilie W.

AU - Nordestgaard, Liv T.

AU - Frikke-Schmidt, Ruth

PY - 2021

Y1 - 2021

N2 - High density lipoprotein (HDL) cholesterol has traditionally been considered the “good cholesterol”, and most of the research regarding HDL cholesterol has for decades revolved around the possible role of HDL in atherosclerosis and its therapeutic potential within atherosclerotic cardiovascular disease. Randomized trials aiming at increasing HDL cholesterol have, however, failed and left questions to what role HDL cholesterol plays in human health and disease. Recent observational studies involving non-cardiovascular diseases have shown that high levels of HDL cholesterol are not necessarily associated with beneficial outcomes as observed for age-related macular degeneration, type II diabetes, dementia, infection, and mortality. In this narrative review, we discuss these interesting associations between HDL cholesterol and non-cardiovascular diseases, covering observational studies, human genetics, and plausible mechanisms.

AB - High density lipoprotein (HDL) cholesterol has traditionally been considered the “good cholesterol”, and most of the research regarding HDL cholesterol has for decades revolved around the possible role of HDL in atherosclerosis and its therapeutic potential within atherosclerotic cardiovascular disease. Randomized trials aiming at increasing HDL cholesterol have, however, failed and left questions to what role HDL cholesterol plays in human health and disease. Recent observational studies involving non-cardiovascular diseases have shown that high levels of HDL cholesterol are not necessarily associated with beneficial outcomes as observed for age-related macular degeneration, type II diabetes, dementia, infection, and mortality. In this narrative review, we discuss these interesting associations between HDL cholesterol and non-cardiovascular diseases, covering observational studies, human genetics, and plausible mechanisms.

KW - Alzheimer’s disease

KW - Blindness

KW - Diabetes

KW - Drusen

KW - Epidemiology

KW - Genetics

KW - High-density lipoprotein

KW - Infection

KW - Mortality

U2 - 10.3390/ijms22094547

DO - 10.3390/ijms22094547

M3 - Review

C2 - 33925284

AN - SCOPUS:85104599006

VL - 22

JO - International Journal of Molecular Sciences (CD-ROM)

JF - International Journal of Molecular Sciences (CD-ROM)

SN - 1424-6783

IS - 9

M1 - 4547

ER -

ID: 261055266